COMPANY

Rithim Biologics Inc.

Location: Woodbine, MD · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $769K (SBIR Phase II 5R44HL172541-03, continuation, notice Sep 14, 2026). NIH RePORTER 5R44HL172541-03 (Sep 14, 2026)
Evidence (1 event)
- Sep 14, 2026 · NIH RePORTER 5R44HL172541-03
  Organization: RITHIM BIOLOGICS, INC.; City/State: WOODBINE, MD; Project number: 5R44HL172541-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-14; FY total cost (award amount): 768857; Administering IC: National Heart Lung and Blood Institute; Project title: Novel Gene Therapy, Techniques, and Devices to Prevent Ventricular Tachycardia; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Sep 14, 2026 Grant Government grant — SBIR: $768,857 (annual award, as published), announced Sep 14, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
Sep 8, 2025 Grant Government grant — SBIR: $1.07M (annual award, as published), announced Sep 8, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗

Last 2 years.

Sep 14, 2026 Government grant — SBIR: $768,857 (annual award, as published), announced Sep 14, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
Sep 8, 2025 Government grant — SBIR: $1.07M (annual award, as published), announced Sep 8, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗

Annual award amounts. Total $578K.

Aug 6, 2024 NIH award 1R44HL172541-01 FY2024: $317,285 awarded for that fiscal year; activity R44 (SBIR); PI ANDERSON, RONALD LEE; recipient as written: RITHIM BIOLOGICS, INC., WOODBINE, MD. Novel Gene Therapy, Techniques, and D source ↗
Aug 9, 2018 NIH award 1R41TR002425-01 FY2018: $260,403 awarded for that fiscal year; activity R41 (STTR); PI DONAHUE, J KEVIN; recipient as written: RITHIM BIOLOGICS, INC., WOODBINE, MD. Catheter Development for Epicardial Atria source ↗